Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice
about
History of medical mycology in the united states.Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune responseDifferential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolatesTransfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.In vitro interactions of immune lymphocytes and Cryptococcus neoformans.Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformans during neuropathogenesis in mice.Requirement for CD4(+) T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice.CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune responseRegulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells.Development of an aerosol model of Cryptococcus reveals humidity as an important factor affecting the viability of Cryptococcus during aerosolization.Cryptococcus neoformans requires a functional glycolytic pathway for disease but not persistence in the hostEffects of cyclosporin A on the cells responsible for the anticryptococcal cell-mediated immune response and its regulation.Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic miceClearance of Cryptococcus neoformans from immunologically suppressed miceIntravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytesLoss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence.Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cellsThe mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies.Cellular immunity in a cutaneous model of cryptococcosisImmunization of mice by intracutaneous inoculation with viable virulent Cryptococcus neoformans: immunological and histopathological parameters.T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice.Characterization of a cell population which amplifies the anticryptococcal delayed-type hypersensitivity response.Characterization of an in vitro-stimulated, Cryptococcus neoformans-specific second-order suppressor T cell and its precursor.Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s)Effects of first-order Cryptococcus-specific T-suppressor cells on induction of cells responsible for delayed-type hypersensitivityIntracellular Action of a Secreted Peptide Required for Fungal Virulence.Colonization and pathogenesis of Cryptococcus neoformans in gnotobiotic mice.Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans.Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan.
P2860
Q30452877-A6AA303F-3AB2-49E9-853B-1A61F3027851Q33602419-4726B9C2-2A2D-4B10-AAEA-8D5C3842811BQ33614286-DA1919A9-2241-401E-9177-03A30E86AEB3Q33877219-BE4D2466-4C08-4345-850F-A655B4B41578Q33908408-A70563E3-A316-4A6B-A4A7-2781CAD001B4Q33912930-62EB711F-FEAE-4178-AE84-F7E520B891D3Q33999899-854B1B55-2076-4D98-B2EA-7569F1723573Q34003156-29C2CDE2-CCFA-4569-99C1-60FD01F68C20Q34007765-E0A52738-A45D-4B0A-8694-9B0DE6AE3AA8Q34530361-93526EB6-3663-40DD-B05A-AE680ED9BCE8Q34532590-4001C205-7C4F-4E2D-BB25-3AC807CDD51CQ34874531-D8D41000-9B12-45FA-9928-C1ABE59F1B94Q35032086-05440B8E-5357-4C4C-AACD-99BD2DF62AD1Q35094163-5EBD03AF-D90C-4EE3-9030-5E9928D470E1Q35105915-D46F75EE-3BBD-4D86-81AE-6749D256D809Q35110910-83C8BDE1-AB3A-4A9B-98E2-2FB471F95223Q35390183-46196EEA-6CB0-441F-83DB-61C8D5A59487Q35406776-F2C074B3-F94B-4367-BC09-0461A5534F0CQ35781610-F114CF4F-AEF6-49FC-901C-3FBA9FCD101AQ36229937-7D5994E6-AE21-470C-8882-DAB200E2633CQ36230201-5132DE99-62B1-423D-92AD-A955C167D143Q36348479-38805873-2354-4DAC-ADF4-4E2DF742D7FFQ36436493-9F0C7E6F-EC75-42DB-B1BA-9856971F93AAQ36962280-11DB3772-7AD3-4646-B825-63CF8D13AD42Q36976638-C39541C2-E013-4B28-B40C-5915E7D8A835Q37004766-76FFB8B4-47EE-439C-864B-8DA499C75A61Q37021060-F4AC847E-DFF1-4E12-946C-212D2FB152CCQ37035844-EA055D47-5AE1-49FE-AD4E-CAD960AF682EQ39897181-61E46EAE-8B58-4E74-A870-1880D26BA3D5Q40163952-88B3DF20-DC3E-481B-BCF8-F46977612E96Q40304155-4DDC31F6-63FF-443C-BDCC-4BD20A41C7FDQ40375269-DF5CA3B3-E1CC-4F0C-8AA4-0F097DD5D726
P2860
Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice
description
1980 nî lūn-bûn
@nan
1980 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
name
Host-etiological agent interac ...... induced Cryptococcosis in mice
@ast
Host-etiological agent interac ...... induced Cryptococcosis in mice
@en
type
label
Host-etiological agent interac ...... induced Cryptococcosis in mice
@ast
Host-etiological agent interac ...... induced Cryptococcosis in mice
@en
prefLabel
Host-etiological agent interac ...... induced Cryptococcosis in mice
@ast
Host-etiological agent interac ...... induced Cryptococcosis in mice
@en
P2093
P2860
P1476
Host-etiological agent interac ...... induced Cryptococcosis in mice
@en
P2093
P2860
P304
P407
P577
1980-08-01T00:00:00Z